Lung cancer
Conditions
Interventions
Experimental group: Self-control (Part I):Therefore, it is necessary to carry out a consistency test between the wearable device (Xiaomi bracelet) and the medical monitor, dynamically collect the pati
Intervention group (Part II):1. Daily Exercise Prescription:
Time: Developed by the rehabilitation therapist before 17:00 each day based on the data collected on that day.
Aerobic Training: Controlled
Control group (Part II):Usual care
Sponsors
Peking University Cancer Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Part I: Age 18-75 years Patients 24-72 hours after radical resection of thoracoscopic lung cancer Clear awareness and able to cooperate with monitoring Voluntarily sign the informed consent form Part 2: Age 18-75 years Patients 24-72 hours after radical resection of thoracoscopic lung cancer Clear awareness and able to cooperate with monitoring Voluntarily sign the informed consent form
Exclusion criteria
Exclusion criteria: Part I: Combined with severe arrhythmias Skin allergies Limb mobility disorders affect device wear Combined with other vital organ failure Part 2: Combined with severe arrhythmias Skin allergies Limb mobility disorders affect device wear Combined with other vital organ failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary Function Recovery Rate (FEV1% Predicted Value);Consistency of Xiaomi Mi Band and Medical Monitor in Heart Rate Monitoring Data (Part 1);Lung function recovery rate (Part II); | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in consistency between heart rate and SpO2 monitoring data at different time points (6 a.m., 12 a.m. during the day, and 20 a.m.) (Part I);Patient adherence to the Xiaomi Mi Band (Part I);Quality of life score (Part II);Rate of change in 6-minute walking distance (Part II);Complication rate (Part II); | — |
Countries
China
Contacts
Public ContactNan Wu
Peking University Cancer Hospital
Outcome results
None listed